{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:25:14Z","timestamp":1765887914025,"version":"3.41.0"},"reference-count":27,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b17-00288","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T22:18:07Z","timestamp":1504217887000},"page":"1586-1589","source":"Crossref","is-referenced-by-count":8,"title":["Limited Azithromycin Localization to Rabbit Meibomian Glands Revealed by LC-MS-Based Bioanalysis and DESI Imaging"],"prefix":"10.1248","volume":"40","author":[{"given":"Nagayoshi","family":"Asano","sequence":"first","affiliation":[{"name":"Nara Research and Development Center, Santen Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin Michael","family":"Wiseman","sequence":"additional","affiliation":[{"name":"Prosolia, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Nara Research and Development Center, Santen Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Kawazu","sequence":"additional","affiliation":[{"name":"Nara Research and Development Center, Santen Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp. Eye Res.<\/i>, 78<\/b>, 347\u2013360 (2004).","DOI":"10.1016\/j.exer.2003.09.019"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Luchs J. Azithromycin in DuraSite\u00ae<\/sup> for the treatment of blepharitis. Clin. Ophthalmol.<\/i>, 4<\/b>, 681\u2013688 (2010).","DOI":"10.2147\/OPTH.S6370"},{"key":"3","unstructured":"3) Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul. Surf.<\/i>, 7<\/b> (Suppl.), S1\u2013S14 (2009)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Haque RM, Torkildsen GL, Brubaker K, Zink RC, Kowalski RP, Mah FS, Pflugfelder SC. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea<\/i>, 29<\/b>, 871\u2013877 (2010).","DOI":"10.1097\/ICO.0b013e3181ca38a0"},{"key":"5","unstructured":"5) Foulks GN, Borchman D, Yappert M, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea<\/i>, 32<\/b>, 44\u201353 (2013)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Opitz DL, Tyler KF. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Clin. Exp. Optom.<\/i>, 94<\/b>, 200\u2013206 (2011).","DOI":"10.1111\/j.1444-0938.2010.00540.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tong L, Gupta PK. Need for animal models of meibomian gland dysfunction. Ophthalmol. Ther.<\/i>, 5<\/b>, 129\u2013134 (2016).","DOI":"10.1007\/s40123-016-0070-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) McMahon A, Lu H, Butovich IA. A role for ELOVL4 in the mouse meibomian gland and sebocyte cell biology. Invest. Ophthalmol. Vis. Sci.<\/i>, 55<\/b>, 2832\u20132840 (2014).","DOI":"10.1167\/iovs.13-13335"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wang Y-C, Li S, Chen X, Ma B, He H, Liu T, Yu J, Zhang L, Chen Y, Liu Z, Li W. Meibomian gland absence related dry eye in ectodysplasin A mutant mice. Am. J. Pathol.<\/i>, 186<\/b>, 32\u201342 (2016).","DOI":"10.1016\/j.ajpath.2015.09.019"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Miyake H, Oda T, Katsuta O, Seno M, Nakamura M. Meibomian gland dysfunction model in hairless mice fed a special diet with limited lipid content. Invest. Ophthalmol. Vis. Sci.<\/i>, 57<\/b>, 3268\u20133275 (2016).","DOI":"10.1167\/iovs.16-19227"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Asano N, Ueda K, Kawazu K. Penetration route of the selective glucocorticoid receptor agonist SA22465 and betamethasone into rabbit meibomian gland based on pharmacokinetics and autoradiography. Drug Metab. Dispos.<\/i>, 45<\/b>, 826\u2013833 (2017).","DOI":"10.1124\/dmd.117.075473"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tak\u00e1ts Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science<\/i>, 306<\/b>, 471\u2013473 (2004).","DOI":"10.1126\/science.1104404"},{"key":"13","unstructured":"13) Wiseman JM, Ifa DR, Zhu Y, Kissinger CB, Manicke NE, Kissinger PT, Cooks RG. Desorption electrospray ionization mass spectrometry: Imaging drugs and metabolites in tissues. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 105<\/b>, 18120\u201318125 (2008)."},{"key":"14","unstructured":"14) Asbell PA, Colby KA, Deng S, McDonnell P, Meisler DM, Raizman MB, Sheppard JD Jr, Sahm DF. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am. J. Ophthalmol.<\/i>, 145<\/b>, 951\u2013958 (2008)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Akpek EK, Vittitow J, Verhoeven RS, Brubaker K, Amar T, Powell KD, Boyer JL, Crean C. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation. J. Ocul. Pharmacol. Ther.<\/i>, 25<\/b>, 433\u2013439 (2009).","DOI":"10.1089\/jop.2009.0026"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhang L, Su Z, Zhang Z, Lin J, Li D-Q, Pflugfelder SC. Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease. JAMA Ophthalmol.<\/i>, 133<\/b>, 1117\u20131123 (2015).","DOI":"10.1001\/jamaophthalmol.2015.2326"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombol\u00e0 L, Carnuccio R, Iuvone T, D\u2019Acquisto F, Di Rosa M. Anti-inflammatory activity of macrolide antibiotics. J. Pharmacol. Exp. Ther.<\/i>, 292<\/b>, 156\u2013163 (2000).","DOI":"10.1016\/S0022-3565(24)35272-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Banjanac M, Muni\u0107 Kos V, Nuji\u0107 K, Vran\u010di\u0107 M, Belamari\u0107 D, Crnkovi\u0107 S, Hlevnjak M, Erakovi\u0107 Haber V. Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells. Pharmacol. Res.<\/i>, 66<\/b>, 357\u2013362 (2012).","DOI":"10.1016\/j.phrs.2012.06.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Liu Y, Kam WR, Ding J, Sullivan DA. Effect of azithromycin on lipid accumulation in immortalized human meibomian gland epithelial cells. JAMA Ophthalmol.<\/i>, 132<\/b>, 226\u2013228 (2014).","DOI":"10.1001\/jamaophthalmol.2013.6030"},{"key":"20","unstructured":"20) Liu Y, Kam WR, Ding J, Sullivan DA. One man\u2019s poison is another man\u2019s meat: using azithromycin-induced phospholipidosis to promote ocular surface health. Toxicology<\/i>, 320<\/b>, 1\u20135 (2014)."},{"key":"21","unstructured":"21) Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW. Topical azithromycin therapy of meibomian gland dysfunction: clinical response and lipid alterations. Cornea<\/i>, 29<\/b>, 781\u2013788 (2010)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Amar T, Caillaud T, Elena P-P. Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits. Curr. Eye Res.<\/i>, 33<\/b>, 149\u2013158 (2008).","DOI":"10.1080\/02713680701860499"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Stewart WC, Crean CS, Zink RC, Brubaker K, Haque RM, Hwang DG. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. Am. J. Ophthalmol.<\/i>, 150<\/b>, 744\u2013751.e2 (2010).","DOI":"10.1016\/j.ajo.2010.05.039"},{"key":"24","unstructured":"24) Grey AC. MALDI imaging of the eye: Mapping lipid, protein and metabolite distributions in aging and ocular disease. Int. J. Mass Spectrom.<\/i>, 401<\/b>, 31\u201338 (2016)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Pallitto P, Ablonczy Z, Jones EE, Drake RR, Koutalos Y, Crouch RK, Donello J, Herrmann J. A2E and lipofuscin distributions in macaque retinal pigment epithelium are similar to human. Photochem. Photobiol. Sci.<\/i>, 14<\/b>, 1888\u20131895 (2015).","DOI":"10.1039\/C5PP00170F"},{"key":"26","unstructured":"26) Anderson DMG, Mills D, Spraggins J, Lambert WS, Calkins DJ, Schey KL. High-resolution matrix-assisted laser desorption ionization-imaging mass spectrometry of lipids in rodent optic nerve tissue. Mol. Vis.<\/i>, 19<\/b>, 581\u2013592 (2013)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Matzneller P, Krasniqi S, Kinzig M, S\u00f6rgel F, H\u00fcttner S, Lackner E, M\u00fcller M, Zeitlinger M. Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy. Antimicrob. Agents Chemother.<\/i>, 57<\/b>, 1736\u20131742 (2013).","DOI":"10.1128\/AAC.02011-12"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/9\/40_b17-00288\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T12:12:41Z","timestamp":1750853561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/9\/40_b17-00288\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00288","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2017]]}}}